Abstract: Software testing is a crucial activity in the software development cycle, as it verifies code correctness, reliability, and maintainabilily. Unit testing involves verifying the correctness ...

For more than half a decade now, a Chinese state-aligned threat actor has been spying on Chinese organizations by infecting their trusted software updates. When the SolarWinds breach was unearthed in ...

Two years after revamping its developer programs and pricing, X is expanding the closed beta of a pay-per-use plan for its API to more developers. The social network is accepting applications from ...

Ono Pharmaceutical’s EP4 antagonist hit the primary progression-free survival endpoint in a phase 2 trial in patients with gastric cancer. The biopharma evaluated the Bristol Myers Squibb-partnered ...

Abstract: Software unit testing is one of the important methods to ensure software quality. Traditional test case generation technology has limitations in accurately understanding code structure and ...

INNSBRUCK, Austria, Sept. 22, 2025 /PRNewswire/ -- AV-Comparatives, the leading independent cybersecurity testing lab, today announced the results of its 2025 Endpoint Prevention and Response (EPR) ...

INNSBRUCK, Austria, Sept. 22, 2025 /CNW/ -- AV-Comparatives, the leading independent cybersecurity testing lab, today announced the results of its 2025 Endpoint Prevention and Response (EPR) Test, ...

Bitdefender, a global cybersecurity leader, today announced outstanding results in the AV-Comparatives Endpoint Prevention and Response (EPR) Comparative Report 2025. The independent assessment ...

Cold hydrostatic testing has been completed at unit 7 of the Tianwan nuclear power plant in China's Jiangsu province, China National Nuclear Corporation has announced. The tests mark the first time ...

GitHub officially deprecates its Azure endpoint for model inference, urging users to transition to the new GitHub Models API by October 17, 2025. GitHub has announced the deprecation of the Azure ...

AstraZeneca’s plans to get an amyloidosis drug to market look further out of reach after the pharma’s anti-fibril antibody failed to reduce deaths and hospitalizations in a key phase 3 study. The Big ...